Lv4
660 积分 2022-08-30 加入
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
1个月前
已完结
[The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology]
2个月前
已完结
The Burden of Cardiovascular Disease in China
3个月前
已完结
Association of Non-Hdl-C-To-Hdl-C Ratio with Coronary Lesions and Its Prognostic Performance in First-Onset Nstemi
4个月前
已完结
皖公网安备34019202002308
